Stock Code: 000999 stock abbreviation: China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) No.: 2022-016
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999)
Announcement on adding temporary proposals to the second extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The board of directors of China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) (hereinafter referred to as “the company”) issued the notice on convening the second extraordinary general meeting of shareholders in 2022 (2022-010) on February 16, 2022. The second extraordinary general meeting of shareholders in 2022 is scheduled to be held on Thursday, March 3, 2022 to consider relevant proposals such as restricted stock incentive plan.
On February 20, 2022, the board of directors of the company received the letter on putting forward interim proposals to the second extraordinary general meeting of shareholders in China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) 2022 from the controlling shareholder China Resources Pharmaceutical Holdings Co., Ltd. (hereinafter referred to as “China Resources Pharmaceutical Holdings”). China Resources Pharmaceutical Holdings nominated Mr. Bai Xiaosong, Mr. Cui xingpin and Mr. Zhao Bingxiang as candidates for directors of the eighth board of directors of the company.
After verification, China Resources Pharmaceutical Holdings holds 622569632 shares of the company, accounting for 63.60% of the total share capital of the company. According to the articles of association, shareholders who individually or jointly hold more than 3% of the company’s shares may put forward interim proposals and submit them to the convener in writing 10 days before the general meeting of shareholders. The content of the proposal for nominating director candidates belongs to the terms of reference of the general meeting of shareholders. China Resources Pharmaceutical Holdings is qualified as a sponsor of the general meeting of shareholders. The above proposals have clear topics and specific resolutions. The procedures and contents of this additional temporary proposal comply with relevant laws, administrative regulations, departmental rules, normative documents, articles of association and other relevant provisions.
On February 21, 2022, the fourth meeting of the board of directors of the company in 2022 deliberated and adopted the proposal on the nomination of director candidates of the eighth board of directors of the company by the interim proposal of the controlling shareholder. The total number of directors who concurrently serve as senior managers of the company and staff representatives in the board of directors does not exceed half of the total number of directors of the company, meeting the requirements of relevant laws and regulations. Mr. Bai Xiaosong, Mr. Cui xingpin and Mr. Zhao Bingxiang will be elected at the second extraordinary general meeting of shareholders in 2022 as candidates for directors of the eighth board of directors. The shareholders’ meeting will adopt the cumulative voting system for the election of directors. For details, please refer to the announcement on the resolution of the fourth board meeting in China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) 2022 (2022-018) disclosed by the company in China Securities Journal, securities times and cninfo.com on February 22, 2022.
In addition to the above additional interim proposal, there is no change in other matters listed in the notice on convening the second extraordinary general meeting of shareholders in 2022. For details, see the announcement on Supplementary Notice on convening the second extraordinary general meeting of shareholders in 2022 (2022-017) disclosed by the company in China Securities Journal, securities times and cninfo.com on February 22, 2022. It is hereby announced.
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) board of directors
February 21, 2002
